Broadway Joe's Pain Cream Recall Over Potential Raw Material Contamination (Aug 21, 2026)
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Lexia LLC is recalling 1,200 jars of Broadway Joe's Pain Cream due to CGMP deviations and potential contamination of raw material. The affected lots were distributed only in Colorado.
Reading this FDA recall beyond the headline
This notice was issued by FDA on September 14, 2026 and geographically references Colorado. The FDA classifies this as a Class II recall, with the stated reason "CGMP Deviations: Potential contamination of raw material", distributed distributed in the state of colorado (us).. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
It is tempting to skim, check personal relevance, and move on. The better habit is confirming scope, source, and timestamp first, then reading this alongside related notices instead of drawing a conclusion from one record alone.
Before acting, the primary agency source is available to check alongside this summary. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Lexia LLC initiated a voluntary recall of Broadway Joe's Pain Cream due to CGMP Deviations: Potential contamination of raw material.
Which Products Are Affected
Broadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate 3000mg, HempSeed Oil 2000mg), 4 oz-jar, NDC 83088-8120-6, UPC 8 50041 64004 4. Affected lots are T1110 (Exp: 1/7/2027), T1111 (Exp: 1/9/2027), T1112 (Exp: 1/16/2027), T1113 (Exp: 1/17/2027), and T1114 (Exp: 1/17/2027). A total of 1,200 4 oz-jars were distributed in the state of Colorado.
What You Should Do
The recall was initiated voluntarily by the firm via letter. Consumers in possession of the affected product should refer to the FDA recall notice for additional guidance.
Why This Matters
The Class II recall involves potential contamination that could pose temporary or reversible adverse health consequences.
Source
FDA recall number D-0829-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Getinge PVC Thoracic Catheters Recall Over Bacterial Endotoxin Testing (Aug 7, 2026)
FDA · September 22, 2026
C.R. Bard Foley Catheter Trays Recall Over Pericare Wipes Contamination (Jun 25, 2026)
FDA · September 22, 2026
Given Imaging Bravo CF Capsule Delivery Device Recall Over Detachment Risk
FDA · September 22, 2026
Similar notices nationwide by length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (937 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to September 14, 2026.
Common Questions
Questions readers often have about this FDA recall.